Kevin Bitterman is a Partner at Atlas Venture, a Cambridge, Massachusetts-based venture capital firm specializing. See sector focus and contact routes.
Kevin Bitterman is a Partner at Atlas Venture, a Cambridge, Massachusetts-based venture capital firm specializing in biotechnology and life sciences, where he helps found and build early-stage therapeutic companies. His investment thesis focuses on early-stage life sciences, with a concentration on drug discovery, therapeutic development, and the creation of new biotech companies in the biotechnology sector. While specific check sizes and lead/follow behavior are not publicly detailed in available sources, his role involves active involvement in building companies from the ground up. Notable portfolio companies in his diverse investment history include Bicycle Therapeutics, Remix Therapeutics, Generation Bio, and Editas Medicine, where he served as Interim President. Bitterman holds a Ph.D., which underscores his scientific background in guiding biotech investments, though no distinctive public writing or unique point of view is explicitly documented in the search results. His portfolio spans numerous therapeutics firms such as Neuronetics, Magenta Therapeutics, and Vigil Neuroscience, reflecting a deep focus on innovative medical solutions.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Cambridge.
Investors like Kevin Bitterman · Full investor directory · Investor access · Company funding database